Live Breaking News & Updates on German Institute For Quality

Stay updated with breaking news from German institute for quality. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Aflibercept in AMD: no proof of added benefit

Manufacturer's dossier did not contain any usable data for the comparison with ranibizumab The drug aflibercept (trade name: Eylea) has been approved in Germany since November 2012 for the treatment of wet age-related macular degeneration (AMD). In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG)… ....

Efficiency In Health Care , German Institute For Quality , Medicinal Products , German Institute , Health Care , Federal Joint Committee ,

Automobili Lamborghini closes the first nine months of 2023 with an operating result exceeding the fiscal year 2022

Automobili Lamborghini closes the first nine months of 2023 with an operating result exceeding the fiscal year 2022
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , United States , United Kingdom , Santagata Bolognese , Emilia Romagna , Italy General , Paolo Poma , Stephan Winkelmann , Asia Pacific , German Institute For Quality , Automobili Lamborghini , Agata Bolognese , Direzione Cor Tauri , Managing Director , Middle East , Monterey Car Week , Sant Agata Bolognese , German Institute , Press Release Image , Press Release , Ews Release ,

Zanubrutinib in chronic lymphocytic leukemia:

Zanubrutinib, a second-generation Bruton tyrosine kinase (BTK) inhibitor, is approved for several therapeutic indications. The German Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether the drug has an added benefit compared with the appropriate comparator therapy for adult patients with chronic lymphocytic leukaemia (CLL) after a relapse or in the case of refractory disease, i. e. disease that has not responded to the previous treatment. ....

Efficiency In Health Care Iqwi , German Institute For Quality , German Institute , Health Care , Federal Joint Committee ,

Trastuzumab Deruxtecan Shows Benefits in HER2-Low Breast Cancer

Trastuzumab Deruxtecan Shows Benefits in HER2-Low Breast Cancer
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Katrin Nink , Efficiency In Health Care Iqwi , Iqwig Drug Assessment Department , German Institute For Quality , German Institute , Health Care , Drug Assessment , Medicinal Products , Federal Joint Committee ,

Automobili Lamborghini closes the first nine months of 2023 with an operating result exceeding the fiscal year 2022

Automobili Lamborghini closes the first nine months of 2023 with an operating result exceeding the fiscal year 2022
thenewsmarket.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenewsmarket.com Daily Mail and Mail on Sunday newspapers.

Santagata Bolognese , Emilia Romagna , Italy General , Hong Kong , United States , United Kingdom , Asia Pacific , Stephan Winkelmann , Paolo Poma , German Institute For Quality , Agata Bolognese , Automobili Lamborghini , Direzione Cor Tauri , Managing Director , Middle East , Monterey Car Week , Sant Agata Bolognese , German Institute ,